Seeing Is Believing
Currently out of the existing stock ratings of Oren Livnat, 18 are a HOLD (7.66%), 217 are a BUY (92.34%).
Analyst Oren Livnat, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 44.68% that have a potential upside of 50.58% achieved within 265 days.
Oren Livnat’s has documented 427 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PCRX, Pacira Pharmaceuticals at 07-Apr-2025.
Analyst best performing recommendations are on MNLO (MENLO THERAPEUTICS).
The best stock recommendation documented was for VYNE (VYNE THERAPEUTICS) at 5/12/2020. The price target of $180 was fulfilled within 16 days with a profit of $49.68 (38.12%) receiving and performance score of 23.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$30
$7.13 (31.18%)
$32
5 months 13 days ago
(08-May-2025)
4/21 (19.05%)
$4.88 (19.43%)
496
Buy
$65
$42.13 (184.22%)
$70
6 months 14 days ago
(07-Apr-2025)
13/29 (44.83%)
$38.73 (147.43%)
233
Hold
$18
$-4.87 (-21.29%)
$18
9 months 8 days ago
(13-Jan-2025)
1/11 (9.09%)
$-2.55 (-12.41%)
11
Hold
$17
$-5.87 (-25.67%)
$25
11 months 10 days ago
(11-Nov-2024)
4/12 (33.33%)
$0.2 (1.19%)
270
Buy
$18
$-4.87 (-21.29%)
$30
1 years 28 days ago
(23-Sep-2024)
1/4 (25%)
$3.74 (26.23%)
71
What Year was the first public recommendation made by Oren Livnat?